Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-048125
Filing Date
2011-05-10
Accepted
2011-05-10 14:05:22
Documents
10
Period of Report
2011-04-03

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q y90387e10vq.htm 10-Q 332538
2 EX-31.1 y90387exv31w1.htm EX-31.1 11396
3 EX-32.1 y90387exv32w1.htm EX-32.1 6528
10 GRAPHIC y90387y9038700.gif GRAPHIC 2918
  Complete submission text file 0000950123-11-048125.txt   5269410

Data Files

Seq Description Document Type Size
4 EX-101 INSTANCE DOCUMENT jnj-20110403.xml EX-101.INS 580823
5 EX-101 SCHEMA DOCUMENT jnj-20110403.xsd EX-101.SCH 55632
6 EX-101 CALCULATION LINKBASE DOCUMENT jnj-20110403_cal.xml EX-101.CAL 61619
7 EX-101 LABELS LINKBASE DOCUMENT jnj-20110403_lab.xml EX-101.LAB 380989
8 EX-101 PRESENTATION LINKBASE DOCUMENT jnj-20110403_pre.xml EX-101.PRE 250000
9 EX-101 DEFINITION LINKBASE DOCUMENT jnj-20110403_def.xml EX-101.DEF 142003
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0209
Type: 10-Q | Act: 34 | File No.: 001-03215 | Film No.: 11827235
SIC: 2834 Pharmaceutical Preparations